Medicare Enrolled
Dr. Elnaz Tabrizi
Rheumatology · Charlotte, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tabrizi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tabrizi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tabrizi
Dr. Elnaz Tabrizi is a rheumatology specialist in Charlotte, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Tabrizi performed 52,195 Medicare services across 1,766 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tabrizi received a total of $2,981 from 17 pharmaceutical and/or device companies across 138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tabrizi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 33% volume in NC
$2,981 industry payments
Medicare Practice Summary
Medicare Utilization ↗52,195
Medicare services
Top 33% in NC for rheumatology
1,766
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,900 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 19,880 | $5 | $11 |
| Romosozumab injection (Evenity) for osteoporosis | 9,660 | $8 | $25 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
9,600 | $34 | $70 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
3,800 | $10 | $50 |
| Denosumab injection (Prolia/Xgeva) | 3,420 | $18 | $42 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
3,080 | $26 | $119 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
298 | $8 | $38 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
295 | $86 | $250 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
292 | $96 | $360 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
220 | $54 | $175 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
179 | $8 | $25 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
140 | $3 | $15 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
109 | $47 | $181 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
100 | $21 | $125 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
94 | $10 | $50 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
80 | $5 | $180 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
72 | $18 | $97 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
64 | $29 | $159 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
58 | $11 | $82 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
58 | $110 | $314 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
57 | $30 | $117 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
57 | $11 | $113 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
51 | $36 | $137 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
50 | $11 | $62 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
47 | $35 | $375 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
40 | $40 | $240 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
39 | $5 | $63 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
34 | $11 | $53 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
33 | $13 | $74 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
26 | $15 | $66 |
| Rheumatoid factor level | 26 | $6 | $30 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
26 | $1 | $15 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
25 | $13 | $70 |
| Tuberculosis test, enumeration of t-cells A blood test that counts T-cells to help detect tuberculosis infection. |
23 | $98 | $328 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
19 | $54 | $219 |
| Tuberculosis blood test (gamma interferon) A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels. |
19 | $61 | $328 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $116 | $266 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
17 | $4 | $33 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
16 | $5 | $37 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
16 | $41 | $238 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
15 | $3 | $13 |
| Hepatitis B core antibody test A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus. |
14 | $12 | $50 |
| Hepatitis C antibody test A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus. |
14 | $14 | $100 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
14 | $10 | $68 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.2% high complexity
64.2% medium
3.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,981
Total received (2018-2024)
Avg $596/year across 5 years
Bottom 49% in NC for rheumatology
17
Companies
138
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,981 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,260
2023
$1,058
2022
$467
2021
$17
2018
$179
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$229
ABBVIE INC.
$202
Novartis Pharmaceuticals Corporation
$146
AstraZeneca Pharmaceuticals LP
$111
Lilly USA, LLC
$97
E.R. Squibb & Sons, L.L.C.
$89
UCB, Inc.
$87
Radius Health, Inc.
$75
Janssen Biotech, Inc.
$72
PFIZER INC.
$63
Genentech USA, Inc.
$32
Aurinia Pharma U.S., Inc.
$22
GENZYME CORPORATION
$21
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 45.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$643
E.R. Squibb & Sons, L.L.C.
$321
Janssen Biotech, Inc.
$271
AstraZeneca Pharmaceuticals LP
$239
ABBVIE INC.
$228
UCB, Inc.
$220
Lilly USA, LLC
$192
Novartis Pharmaceuticals Corporation
$174
AbbVie Inc.
$143
Radius Health, Inc.
$135
PFIZER INC.
$105
Genentech USA, Inc.
$91
Aurinia Pharma U.S., Inc.
$85
GENZYME CORPORATION
$68
AbbVie, Inc.
$36
Fresenius Kabi USA, LLC
$15
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 41.4% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · Actemra · Bimzelx · COSENTYX · Cimzia · EVENITY · Enbrel · Humira · IDACIO · KEVZARA · KRYSTEXXA · LUPKYNIS · ORENCIA · REMICADE · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · TALTZ · TAVNEOS · TREMFYA · Tavneos · Truxima · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
38
Per 100K population
3.4
County median income
$83,765
Nearest hospital
CAROLINAS MEDICAL CENTER/BEHAV HEALTH
1.5 mi
1.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tabrizi is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tabrizi experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Tabrizi performed 19,880 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tabrizi receive payments from pharmaceutical companies?
Yes. Dr. Tabrizi received a total of $2,981 from 17 companies across 138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tabrizi's costs compare to other rheumatologists in Charlotte?
Dr. Tabrizi's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tabrizi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Charlotte
Browse rheumatologists in Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NC
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NC
Which NC rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology